Pre- and postoperative care for stage I-III NSCLC: Which quality of care indicators are evidence-based?
详细信息 查看全文
- 作者：Rachel C. Numan ; PhDa ; 1 ; r.numan@nki.nl" class="auth_mail" title="E-mail the corresponding author ; Martijn Ten Berge ; PhDb ; 1 ; Jacobus A. Burgers ; MDc ; Houke M. Klomp ; MDa ; Johanna W. van Sandick ; MDa ; Paul Baas ; MDc ; Michel W. Wouters ; MDa
- 关键词：Quality of Care ; Quality indicator ; Lung cancer
- 刊名：Lung Cancer
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：101
- 期：Complete
- 页码：120-128
- 全文大小：1528 K
文摘
- •
Evidence-based quality indicators for the management of stage I–III NSCLC were identified.
- •
The use of the PET-CT and invasive endoscopic techniques are process indicators.
- •
The use of cytology in combination with histology during bronchoscopy is a process indicator.
- •
The use of preoperative chemoradiation for clinical stage III NSCLC is a process indicator.
- •
The use of postoperative chemotherapy for stage II/III NSCLC is a process indicator.